| 
Results for denosumab. Search took 0.01 seconds.
Amgen's Denosumab Increases Bone Mineral Density in Phase 2 Clinical Trials
in The Biotech Weblog, on February 27, 2006
...
Amgen released the results of Phase 2 clinical trials for Denosumab (previously referred to as AMG 162), showing that the RANK Ligand inhibitor significantly increased bone mineral densi...
Amgen Acquires Abgenix for $2.2 B
in The Biotech Weblog, on December 15, 2005
...e says that Amgen gains full ownership over panitumumab, as well as another cancer drug candidate, denosumab :
The acquisition of Abgenix provides Amgen with full ownership of one of its most import...